News 4: Bamlanivimab not easy to pronounce, but provides Texas hospitals new COVID treatment

The first shipments of an experimental antibody therapy for COVID-19 have arrived in Texas. It’s not easy to pronounce, but bamlanivimab has been shown to prevent high-risk patients from ending up in the hospital.

Watch the full story at News 4



Share This Article!
Article Categories: COVID-19 Media Coverage, In the News